Picture 1 of 1
Picture 1 of 1
Physicians' Desk Reference for Prescription Drugs by Medical Economics Company
US $15.99
ApproximatelyPHP 889.72
Condition:
Good
A book that has been read but is in good condition. Very minimal damage to the cover including scuff marks, but no holes or tears. The dust jacket for hard covers may not be included. Binding has minimal wear. The majority of pages are undamaged with minimal creasing or tearing, minimal pencil underlining of text, no highlighting of text, no writing in margins. No missing pages.
Postage:
Free Standard Shipping.
Located in: Sparks, Nevada, United States
Delivery:
Estimated between Thu, 26 Sep and Mon, 30 Sep to 43230
Returns:
30 days return. Buyer pays for return shipping.
Coverage:
Read item description or contact seller for details. See all detailsSee all details on coverage
(Not eligible for eBay purchase protection programmes)
Shop with confidence
Seller assumes all responsibility for this listing.
eBay item number:364285282257
Item specifics
- Condition
- Book Title
- Physicians' Desk Reference for Prescription Drugs
- Publication Date
- 2002-01-01
- Edition Number
- 56
- Pages
- 3635
- ISBN
- 9781563634116
- Subject Area
- Medical
- Publication Name
- Physicians' Desk Référence 2002 : Library/Hospital Version
- Publisher
- PDR Network, LLC
- Item Length
- 12.2 in
- Subject
- Dictionaries & Terminology
- Publication Year
- 2001
- Type
- Textbook
- Format
- Hardcover
- Language
- English
- Features
- Revised
- Item Weight
- 136.2 Oz
- Item Width
- 9.4 in
- Number of Pages
- 3000 Pages
About this product
Product Identifiers
Publisher
PDR Network, LLC
ISBN-10
1563634112
ISBN-13
9781563634116
eBay Product ID (ePID)
1992928
Product Key Features
Number of Pages
3000 Pages
Publication Name
Physicians' Desk Référence 2002 : Library/Hospital Version
Language
English
Subject
Dictionaries & Terminology
Publication Year
2001
Features
Revised
Type
Textbook
Subject Area
Medical
Format
Hardcover
Dimensions
Item Weight
136.2 Oz
Item Length
12.2 in
Item Width
9.4 in
Additional Product Features
Edition Number
56
Table Of Content
Among the new drugs featured in this edition are: Nexium (esomeprazole magnesium), a new proton pump inhibitor approved for the treatment of GERD and H pylori eradication; Canasa (mesalamine), a new anti-inflammatory rectal suppository indicated for the treatment of active ulcerative proctitis; Lumigan (bimatoprost), a new ophthalmic solution approved for the reduction of elevated intraocular pressure associated with open angle glaucoma or ocular hypertension; Advair (fluticasone propionate/salmeterol xinafoate), a new combination inhalation powder approved for the maintenance treatment of asthma; Trizivir (abacavir sulfate/lamivudine/zidovudine), a new combination nucleoside analogue approved for the treatment of HIV-1 infection; Cancidas (caspofungin acetate), the first of a new class of antifungal agents called glucan synthesis inhibitors, is indicated for refractory treatment of invasive aspergillosis; Remeron SolTab (mirtazapine), a new orally disintegrating tablet for the treatment of depression; Lunelle Monthly (medroxyprogesterone acetate/estradiol cypionate), a new long acting contraceptive injection; Gleevec (imatinib mesylate), a new oral protein-tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia (CML); and Valcyte (valganciclovir HC1), the new antiviral prodrug of ganciclovir, is indicated for CMV retinitis in patients with AIDS.
Edition Description
Revised edition
Synopsis
Completely revised and updated, the 2002 PDR provides FDA-approved drug information on more than 4,000 prescription drugs (brand and generic names), over 2,000 full-color, actual-size photos of medicines for instant identification, and important data on over 250 drug manufacturers. New medicines, new drug interaction data, the most recent side effects findings, and certain drugs now removed from the market make it absolutely critical that medical and healthcare professionals keep up-to-date with the very latest prescription drug information. The 2002 PDR contains: the newest drugs-which drugs are indicated for the diagnosed condition; how different drugs interact; latest findings on side effects caused by the prescribed drug; recommended dosages; clinical pharmacology; pediatric use; contraindications; FDA use-in-pregnancy ratings; and more. Among the new drugs featured in this edition are: Nexium (esomeprazole magnesium), a new proton pump inhibitor approved for the treatment of GERD and H. pylori eradication; Canasa (mesalamine), a new anti-inflammatory rectal suppository indicated for the treatment of active ulcerative proctitis; Lumigan (bimatoprost), a new ophthalmic solution approved for the reduction of elevated intraocular pressure associated with open angle glaucoma or ocular hypertension; Advair (fluticasone propionate/salmeterol xinafoate), a new combination inhalation powder approved for the maintenance treatment of asthma; Trizivir (abacavir sulfate/lamivudine/zidovudine), a new combination nucleoside analogue approved for the treatment of HIV-1 infection; Cancidas (caspofungin acetate), the first of a new class of antifungal agents called glucan synthesis inhibitors, is indicated for refractory treatment of invasive aspergillosis; Remeron SolTab (mirtazapine), a new orally disintegrating tablet for the treatment of depression; Lunelle Monthly (medroxyprogesterone acetate/estradiol cypionate), a new long acting contraceptive injection; Gleevec (imatinib mesylate), a new oral protein-tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia (CML); and Valcyte (valganciclovir HCl), the new antiviral prodrug of ganciclovir, is indicated for CMV retinitis in patients with AIDS. New larger trim size allows dramatically improved readability.
Item description from the seller
Seller feedback (473,661)
- p***t (296)- Feedback left by buyer.Past monthVerified purchaseGood deal
- b***j (7)- Feedback left by buyer.Past monthVerified purchaseThank you
- 2***k (550)- Feedback left by buyer.Past monthVerified purchaseGood